211 Ces Urol 2024; 28(3): 205–213 PŘEHLEDOVÉ ČLÁNKY 12. Yang S, Pinney SM, Mallick P, et al. Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study. Clin Genitourin Cancer. říjen 2015; 13(5): e347-351. 13. Gào X, Brenner H, Holleczek B, et al. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up. Free Radical Biology and Medicine [Internet]. 1. srpen 2018 [citován 26. květen 2024]; 123: 20–6. Dostupné z: https://www.sciencedirect.com/science/article/pii/S089158491830889X. 14. Miyake H, Hara I, Kamidono S, Eto H. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol. duben 2004; 171(4): 1533–6. 15. Camphausen K, Ménard C, Sproull M, et al. Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated. Int J Radiat Oncol Biol Phys. 1. duben 2004; 58(5): 1536–9. 16. Brys M, Morel A, Forma E, et al. Relationship of urinary isoprostanes to prostate cancer occurence. Mol Cell Biochem [Internet]. 2013 [citován 26. květen 2024]; 372(1): 149–53. Dostupné z: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC3506833/. 17. Lucarelli G, Rutigliano M, Galleggiante V, et al. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer. Expert Review of Molecular Diagnostics [Internet]. 2. září 2015 [citován 12. červenec 2024]; 15(9): 1211–24. Dostupné z: https://doi.org/10.1586/14737159.2015.1069711. 18. Ferro M, Buonerba C, Terracciano D, et al. Biomarkers in localized prostate cancer. Future Oncol [In‑ ternet]. únor 2016 [citován 12. červenec 2024]; 12(3): 399–411. Dostupné z: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC5549774/. 19. Cao DL, Ye DW, Zhu Y, et al. Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine. Prostate Cancer Prostatic Dis [Internet]. červen 2011 [citován 12. červenec 2024]; 14(2): 166–72. Dostupné z: https://www.nature.com/articles/pcan20112. 20. Heger Z, Cernei N, Gumulec J, et al. Determination of common urine substances as an assay for im‑ proving prostate carcinoma diagnostics. Oncology Reports [Internet]. 1. duben 2014 [citován 1. srpen 2024]; 31(4): 1846–54. Dostupné z: https://www.spandidos-publications.com/10.3892/or.2014.3054. 21. Sreekumar A, Poisson LM, Rajendiran TM, et al. Metabolomic Profiles Delineate Potential Role for Sarcosine in Prostate Cancer Progression. Nature [Internet]. 12. únor 2009 [citován 12. červenec 2024]; 457(7231): 910–4. Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724746/. 22. Duskova K, Vesely S, DO Carmo Silva J, et al. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors. In Vivo. [Internet]. [citován 8. listopad 2024]. 2018; 32(2): 425–9. Dostupné z: https://pubmed.ncbi.nlm.nih. gov/29475932/. 23. Cernei N, Zitka O, Skalickova S, et al. Sarkosin v moči pacientů se zhoubným nádorem prostaty [In‑ ternet]. [citován 8. listopad 2024]. Dostupné z: https://www.prolekare.cz/casopisy/prakticky-lekar/2012-8/ sarkosin-v-moci-pacientu-se-zhoubnym-nadorem-prostaty-39112. 24. Stephan C, Rittenhouse H, Hu X, Cammann H, Jung K. Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa). EJIFCC [Internet]. 28. duben 2014 [citován 24. červenec 2024]; 25(1): 55–78. Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975191/. 25. Shamsipur M, Naseri MT, Babri M. Quantification of candidate prostate cancer metabolite biomarkers in urine using dispersive derivatization liquid-liquid microextraction followed by gas and liquid chromato‑ graphy–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis [Internet]. 1. červenec 2013 [citován 1. srpen 2024]; 81–82: 65–75. Dostupné z: https://www.sciencedirect.com/science/article/pii/ S0731708513001374.
RkJQdWJsaXNoZXIy NDA4Mjc=